Antimicrobial resistance has become an important public health concern in Nigeria. Many infections that were once easier to treat can become more difficult when microorganisms develop resistance to the medicines used against them. This creates challenges for patients healthcare professionals hospitals laboratories and the wider community.
Understanding amr in nigeria is important because antimicrobial resistance is not caused by one person one hospital or one type of medicine. It is connected to how antimicrobial medicines are used how infections spread access to diagnosis medicine quality healthcare systems and activities involving animals and the environment.
Nigeria has been strengthening its response through national policies antimicrobial stewardship surveillance infection prevention research and public awareness. The country's Second One Health Antimicrobial Resistance National Action Plan covers the period from 2024 to 2028 and provides a framework for coordinated action against AMR.
Understanding AMR in Nigeria
AMR stands for antimicrobial resistance. It occurs when microorganisms such as bacteria viruses fungi and parasites become able to survive medicines that are intended to control or treat them.
Antibiotic resistance is one form of AMR. It happens when bacteria become resistant to antibiotics. However AMR is broader because it can involve resistance to medicines used against several types of microorganisms.
When resistance develops an infection may become more difficult to treat. A patient may require alternative medicines additional testing or longer medical care. In serious cases resistant infections can contribute to severe illness and death.
The issue is therefore not simply about whether a particular antibiotic works. It is about protecting the effectiveness of antimicrobial medicines for patients who need them.
Factors Driving AMR in Nigeria
There are several factors connected to amr in nigeria. One major concern is inappropriate antimicrobial use.
Some people may take antibiotics without proper medical advice use medicines left over from previous illnesses or believe antibiotics are necessary whenever they have symptoms of an infection. However antibiotics do not treat viral infections and the correct treatment depends on the cause of the illness.
Limited access to diagnostic testing can also make appropriate treatment more difficult. When healthcare professionals do not have enough information about the cause of an infection treatment may sometimes begin before the specific microorganism is identified.
Other challenges include gaps in infection prevention medicine quality public awareness laboratory capacity and antimicrobial use in different sectors.
These factors are connected which is why AMR requires a coordinated response rather than a single solution.
The Impact on Healthcare
AMR can place additional pressure on Nigeria's healthcare system.
When infections become resistant to commonly used medicines healthcare professionals may need to consider alternative treatments. Some patients may require longer treatment or closer monitoring.
Resistant infections can also increase the cost of care for patients and healthcare facilities. Longer hospital stays can affect families financially and place additional demands on healthcare workers and available resources.
AMR can also affect important medical services. Effective antimicrobial treatment is an important part of modern healthcare including the management of serious infections and protection against infections associated with some medical procedures.
This makes protecting antimicrobial effectiveness important not only for infectious disease treatment but also for the wider healthcare system.
The Importance of AMR Surveillance
Surveillance is an important part of the response to amr in nigeria.
AMR surveillance involves collecting and analyzing information about resistant microorganisms and antimicrobial use. This information can help healthcare professionals and public health authorities understand changing resistance patterns.
Reliable data can also support treatment guidelines antimicrobial stewardship programs laboratory planning and national health policies.
Nigeria's NAP 2.0 identifies surveillance and detection as key areas of action. The national plan aims to strengthen systems that can provide better information about AMR across the country.
Improving surveillance is particularly important because resistance patterns can differ between locations healthcare facilities and types of infection. Local data can therefore provide valuable information for local decision-making.
Antimicrobial Stewardship in Nigeria
Antimicrobial stewardship is another important part of Nigeria's AMR response.
The purpose of stewardship is to ensure that antimicrobial medicines are used appropriately. This includes choosing the appropriate medicine when treatment is needed using the correct dose and avoiding unnecessary antimicrobial exposure.
Doctors pharmacists nurses laboratory professionals and other healthcare workers all have roles in antimicrobial stewardship.
Healthcare facilities can establish stewardship programs that review antimicrobial use support evidence-based prescribing monitor treatment practices and educate healthcare professionals.
NNAST supports efforts to strengthen antimicrobial stewardship at national subnational and healthcare facility levels. Its terms of reference include supporting stewardship programs promoting rational antimicrobial use strengthening surveillance and helping healthcare facilities develop approaches based on local data.
Infection Prevention Can Make a Difference
Preventing infections is one of the practical ways to reduce the need for antimicrobial medicines.
Good hand hygiene safe water sanitation vaccination food safety appropriate waste management and infection prevention practices can help reduce the spread of infectious diseases.
Healthcare facilities also need strong infection prevention and control systems. These measures can reduce the transmission of infections between patients healthcare workers and visitors.
When fewer infections occur fewer people need antimicrobial treatment. This can reduce unnecessary antimicrobial exposure and support wider efforts to control resistance.
NNAST's vision includes stronger infection prevention responsible antimicrobial use and surveillance across Nigeria's healthcare system.
Better Diagnostics and Laboratory Services
Laboratories play an important role in tackling amr in nigeria.
Diagnostic testing can help identify the microorganism responsible for an infection. When appropriate antimicrobial susceptibility testing can also help determine which medicines are likely to work against a particular organism.
Better laboratory services can support more informed treatment decisions and reduce unnecessary use of broad-spectrum medicines.
However laboratory capacity needs to be available and supported with trained staff reliable equipment quality systems and appropriate reporting networks.
Strengthening these systems is part of Nigeria's national AMR strategy. NAP 2.0 includes improved access to diagnostics and capacity building among its priorities.
Public Awareness and Responsible Medicine Use
Public awareness is another important part of addressing AMR.
People need to understand that antibiotics are not appropriate for every illness. They should also know the risks of sharing medicines using leftover antibiotics or taking antimicrobial medicines without appropriate professional guidance.
Clear health information can help people make better decisions when they become ill.
Healthcare professionals schools community organizations government agencies media organizations and public health groups can all contribute to AMR education.
NNAST also supports health education and awareness activities aimed at healthcare professionals and the general public.
AMR and the One Health Approach
AMR does not exist only within hospitals. Resistant microorganisms can move between humans animals food systems agriculture and the environment.
This is why Nigeria's national response follows a One Health approach. The Second One Health AMR National Action Plan brings together relevant sectors to address the problem through coordinated action.
The approach recognizes that antimicrobial use in humans animals and other sectors can influence the wider resistance problem.
Working across sectors can help Nigeria understand the full picture of AMR and develop more coordinated responses.
NNAST's Role in Nigeria's AMR Response
NNAST the Nigerian National Antimicrobial Stewardship Taskforce brings together expertise from different areas related to antimicrobial stewardship and AMR.
Its mandate includes supporting coordination with government and non-government organizations healthcare professionals researchers universities and other stakeholders. NNAST also works to support policy development surveillance education research and antimicrobial stewardship.
The organization aims to help connect policy with practical implementation and strengthen collaboration across Nigeria's AMR response.
This type of cooperation is important because AMR cannot be addressed effectively by one organization working alone.
Conclusion
AMR in Nigeria is a complex public health challenge that affects patients healthcare professionals hospitals laboratories communities and other sectors. Inappropriate antimicrobial use limited diagnostics infection prevention gaps and weaknesses in surveillance and healthcare systems can all contribute to the problem.
Nigeria is responding through its Second One Health Antimicrobial Resistance National Action Plan 2024–2028 with priorities that include surveillance infection prevention antimicrobial stewardship diagnostics research public awareness and healthcare system strengthening.
Organizations such as NNAST have an important role in supporting these efforts through education stewardship surveillance research coordination and collaboration. Continued action from healthcare professionals government agencies researchers communities and other sectors can help Nigeria strengthen its response to AMR and protect effective antimicrobial medicines for future generations.
